Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens. LPI (LP Information)' newest research report, the ﾓNewcastle Disease Vaccine Industry Forecastﾔ looks at past sales and reviews total world Newcastle Disease Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Newcastle Disease Vaccine sales for 2023 through 2029. With Newcastle Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newcastle Disease Vaccine industry. This Insight Report provides a comprehensive analysis of the global Newcastle Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Newcastle Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Newcastle Disease Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newcastle Disease Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newcastle Disease Vaccine. The global Newcastle Disease Vaccine market size is projected to grow from US$ 308 million in 2022 to US$ 389.8 million in 2029; it is expected to grow at a CAGR of 389.8 from 2023 to 2029. Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%. This report presents a comprehensive overview, market shares, and growth opportunities of Newcastle Disease Vaccine market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Live Vaccines Killed Vaccines Segmentation by application Chicken Duck & Goose Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Merial CEVA QYH Biotech Ringpu Biology Yebio Harbin Veterinary Research Institute Merck Animal Health DHN Zoetis ChengDu Tecbond Elanco (Lohmann) FATRO CAVAC Vaksindo Key Questions Addressed in this Report What is the 10-year outlook for the global Newcastle Disease Vaccine market? What factors are driving Newcastle Disease Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Newcastle Disease Vaccine market opportunities vary by end market size? How does Newcastle Disease Vaccine break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Newcastle Disease Vaccine Annual Sales 2018-2029 2.
